Correction to: Oncogene
https://doi.org/10.1038/s41388-018-0577-5 published online 26 November 2018
Following publication of this article, the authors noted that they accidentally misplaced the figure in supplementary Fig. 7b when re-editing the figures to meet the format and the image resolution of the journal. The amended version of supplementary Fig. 7 is provided below. This change does not affect the results or conclusions reported in the paper.
a Transwell chamber analysis of control or LOX silenced OV56 cells transfected with miR-508-3p inhibitor. b Transwell chamber analysis of control or LOX-overexpressing COV504 cells transfected with miR-508-3p mimic. In all bar plots, p-values are based on two-tailed Student's t-tests (*P < 0.05, **P < 0.01, ***P < 0.001)
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41388-018-0577-5.
Rights and permissions
About this article
Cite this article
Zhao, L., Wang, W., Xu, L. et al. Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer. Oncogene 38, 7279–7280 (2019). https://doi.org/10.1038/s41388-019-0896-1
Published:
Issue date:
DOI: https://doi.org/10.1038/s41388-019-0896-1
